These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25455159)
21. Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients. Otto W; Denzinger S; Fritsche HM; Burger M; Rößler W; Bertz S; May M; Hartmann A; Hofstädter F; Wieland WF; Eder F Clin Genitourin Cancer; 2013 Dec; 11(4):537-44. PubMed ID: 23850551 [TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
23. Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis. Wang H; Men CP Lab Med; 2015; 46(2):118-22. PubMed ID: 25918190 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237 [TBL] [Abstract][Full Text] [Related]
25. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer. Zhou WB; Zhong CN; Luo XP; Zhang YY; Zhang GY; Zhou DX; Liu LP Biochem Biophys Res Commun; 2016 Feb; 470(4):838-44. PubMed ID: 26806308 [TBL] [Abstract][Full Text] [Related]
26. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Li W; Yuan Y; Huang L; Qiao M; Zhang Y Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617 [TBL] [Abstract][Full Text] [Related]
29. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells. Chandrasekaran KS; Sathyanarayanan A; Karunagaran D Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1. Zhang X; Tao T; Liu C; Guan H; Huang Y; Xu B; Chen M Oncol Rep; 2016 Jul; 36(1):376-82. PubMed ID: 27175617 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of microRNA-93 downregulation in human colon cancer. Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160 [TBL] [Abstract][Full Text] [Related]
33. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Wei JJ; Wu X; Peng Y; Shi G; Basturk O; Yang X; Daniels G; Osman I; Ouyang J; Hernando E; Pellicer A; Rhim JS; Melamed J; Lee P Clin Cancer Res; 2011 Mar; 17(6):1297-305. PubMed ID: 21138859 [TBL] [Abstract][Full Text] [Related]
35. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer. Zhang Z; Wang Q; Chen F; Liu J Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216 [TBL] [Abstract][Full Text] [Related]
36. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Allory Y; Beukers W; Sagrera A; Flández M; Marqués M; Márquez M; van der Keur KA; Dyrskjot L; Lurkin I; Vermeij M; Carrato A; Lloreta J; Lorente JA; Carrillo-de Santa Pau E; Masius RG; Kogevinas M; Steyerberg EW; van Tilborg AA; Abas C; Orntoft TF; Zuiverloon TC; Malats N; Zwarthoff EC; Real FX Eur Urol; 2014 Feb; 65(2):360-6. PubMed ID: 24018021 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5. Xu T; Qin L; Zhu Z; Wang X; Liu Y; Fan Y; Zhong S; Wang X; Zhang X; Xia L; Zhang X; Xu C; Shen Z Oncotarget; 2016 May; 7(19):27445-57. PubMed ID: 27050274 [TBL] [Abstract][Full Text] [Related]
38. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017 [TBL] [Abstract][Full Text] [Related]
39. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
40. microRNA-26a-5p affects myocardial injury induced by coronary microembolization by modulating HMGA1. Kong B; Qin Z; Ye Z; Yang X; Li L; Su Q J Cell Biochem; 2019 Jun; 120(6):10756-10766. PubMed ID: 30652345 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]